Real-time enrollment status for this acute promyelocytic leukemia clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 9:54 PM UTC
| NCT Number | NCT01409161 |
| Recruiting Status | Recruiting |
| Condition | Acute Promyelocytic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 151 participants |
| Active Locations | 5 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 22, 2026: Clinical trial NCT01409161 is currently recruiting participants. This phase2 study for acute promyelocytic leukemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01409161 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01409161 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.